244
Views
15
CrossRef citations to date
0
Altmetric
Brief Report

Economic implications of using pegfilgrastim rather than conventional G-CSF to prevent neutropenia during small-cell lung cancer chemotherapy

, , , , &
Pages 1455-1460 | Accepted 13 Mar 2009, Published online: 06 May 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Omer Ben-Aharon, Georgi Iskrov, Iftach Sagy & Dan Greenberg. (2023) Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 23:3, pages 281-295.
Read now
Pierre Rofail, Mariam Tadros, Riham Ywakim, Mina Tadrous, Allison Krug & Leon E Cosler. (2012) Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 699-709.
Read now

Articles from other publishers (13)

Yaqin Wang, Chenglong Zhao, Peizhi Ma & Dandan Jiang. (2023) Outcome and Cost-Effectiveness Analysis of Long-acting G-CSF as Primary Prophylaxis of Neutropenia Induced by Chemotherapy in Breast Cancer Patients, From a Retrospective Study. Cancer Control 30, pages 107327482211402.
Crossref
Ramin Madanchi, Nils W. Engel, Winfried Alsdorf, Christoph Oing, Christian Frenzel, Finn-Ole Paulsen, Carsten Bokemeyer & Christoph Seidel. (2022) Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients. Bone Marrow Transplantation 57:5, pages 729-733.
Crossref
Ashley Enstone, Maire Greaney, Manca Povsic, Robin Wyn, John R. Penrod & Yong Yuan. (2017) The Economic Burden of Small Cell Lung Cancer: A Systematic Review of the Literature. PharmacoEconomics - Open 2:2, pages 125-139.
Crossref
Jew W. Kuan, Anselm T. Su & Chooi F. Leong. (2017) Pegylated granulocyte-colony stimulating factor versus non-pegylated granulocyte-colony stimulating factor for peripheral blood stem cell mobilization: A systematic review and meta-analysis. Journal of Clinical Apheresis 32:6, pages 517-542.
Crossref
Sarah Mitchell, Xiaoyan Li, Matthew Woods, Jacob Garcia, Kerri Hebard-Massey, Rich Barron & Miny Samuel. (2016) Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review. Journal of Oncology Pharmacy Practice 22:5, pages 702-716.
Crossref
Jew-Win Kuan, Anselm Ting Su, Chooi-Fun Leong & Prathap Tharyan. (2016) Pegylated granulocyte colony stimulating factor versus non-pegylated granulocyte colony stimulating factor for peripheral stem cell mobilization. Cochrane Database of Systematic Reviews.
Crossref
Chun-Ru Chien, Te-Chun Hsia & Chih-Yi Chen. (2014) Cost-effectiveness of chemotherapy combined with thoracic radiotherapy versus chemotherapy alone for limited stage small cell lung cancer: A population-based propensity-score matched analysis. Thoracic Cancer 5:6, pages 530-536.
Crossref
Karen Tomic, Stacey Long, Xiaoyan Li, An-Chen Fu, Tzy-Chyi Yu & Richard Barron. (2013) A retrospective study of patients’ out-of-pocket costs for granulocyte colony-stimulating factors. Journal of Oncology Pharmacy Practice 19:4, pages 328-337.
Crossref
Frank G. Sandmann, Margreet G. Franken, Adri Steenhoek & Marc A. Koopmanschap. (2013) Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time. Health Policy 112:3, pages 285-296.
Crossref
Jew-Win Kuan, Anselm Ting Su & Chooi-Fun Leong. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Bernd C. Kieseier & Peter A. Calabresi. (2012) PEGylation of Interferon-β-1a. CNS Drugs 26:3, pages 205-214.
Crossref
Mélisande Bernard, Mélanie Brignone, Alain Adehossi, Samuel Pefoura, Caroline Briquet, Christos Chouaid & Patrick Tilleul. (2011) Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: A willingness to pay study. Lung Cancer 72:1, pages 114-118.
Crossref
Erin W. Hofstatter. (2010) Understanding Patient Perspectives on Communication About the Cost of Cancer Care: A Review of the Literature. Journal of Oncology Practice 6:4, pages 188-192.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.